Evidence map›Paper›PMID 26159999›Full record

ArticleEuropean heart journal2015

Rare genetic variants previously associated with congenital forms of long QT syndrome have little or no effect on the QT interval.

Jonas Ghouse, Christian Theil Have, Peter Weeke, Jonas Bille Nielsen, Gustav Ahlberg, Marie Balslev-Harder, Emil Vincent Appel, Tea Skaaby, Søren-Peter Olesen, Niels Grarup and 7 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in European heart journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 59 citations in OpenAlex.

  1. Functional Profiling ofCirculation. Genomic and precision medicine · 2025
    Article
  2. Reappraisal ofReviews in cardiovascular medicine · 2025
    Review
  3. Evaluating gradient-based explanation methods for neural network ECG analysis using heatmaps.Journal of the American Medical Informatics Association : JAMIA · 2025
    Article
  4. Review
  5. Enhancing the interpretation of genetic observations in KCNQ1 in unselected populations: relevance to secondary findings.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. InvestigatingInternational journal of molecular sciences · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 1 country.

Jonas GhouseThe Danish National Research Foundation Centre for Cardiac Arrhythmia, Copenhagen, Denmark Laboratory of Molecular Cardiology, Department of Cardiology, The Heart Centre, University Hospital of Copenhagen, Rigshospitalet, 9312, Juliane Mariesvej 20, Copenhagen OE 2100, Denmark.
Christian Theil HaveThe Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Peter WeekeThe Danish National Research Foundation Centre for Cardiac Arrhythmia, Copenhagen, Denmark Laboratory of Molecular Cardiology, Department of Cardiology, The Heart Centre, University Hospital of Copenhagen, Rigshospitalet, 9312, Juliane Mariesvej 20, Copenhagen OE 2100, Denmark.
Jonas Bille NielsenThe Danish National Research Foundation Centre for Cardiac Arrhythmia, Copenhagen, Denmark Laboratory of Molecular Cardiology, Department of Cardiology, The Heart Centre, University Hospital of Copenhagen, Rigshospitalet, 9312, Juliane Mariesvej 20, Copenhagen OE 2100, Denmark.
Gustav AhlbergThe Danish National Research Foundation Centre for Cardiac Arrhythmia, Copenhagen, Denmark Laboratory of Molecular Cardiology, Department of Cardiology, The Heart Centre, University Hospital of Copenhagen, Rigshospitalet, 9312, Juliane Mariesvej 20, Copenhagen OE 2100, Denmark.
Marie Balslev-HarderThe Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Emil Vincent AppelThe Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Tea SkaabyResearch Centre for Prevention and Health, The Capital Region, Copenhagen, Denmark.
Søren-Peter OlesenThe Danish National Research Foundation Centre for Cardiac Arrhythmia, Copenhagen, Denmark.
Niels GrarupThe Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Allan LinnebergResearch Centre for Prevention and Health, The Capital Region, Copenhagen, Denmark Department of Clinical Experimental Research, Glostrup University Hospital, Denmark Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Oluf PedersenThe Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Stig HaunsøThe Danish National Research Foundation Centre for Cardiac Arrhythmia, Copenhagen, Denmark Laboratory of Molecular Cardiology, Department of Cardiology, The Heart Centre, University Hospital of Copenhagen, Rigshospitalet, 9312, Juliane Mariesvej 20, Copenhagen OE 2100, Denmark Department of Medicine and Surgery, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Jesper Hastrup SvendsenThe Danish National Research Foundation Centre for Cardiac Arrhythmia, Copenhagen, Denmark Laboratory of Molecular Cardiology, Department of Cardiology, The Heart Centre, University Hospital of Copenhagen, Rigshospitalet, 9312, Juliane Mariesvej 20, Copenhagen OE 2100, Denmark Department of Medicine and Surgery, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Torben HansenThe Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Jørgen Kim KantersLaboratory of Experimental Cardiology, Department of Biomedicine, University of Copenhagen, Copenhagen, Denmark Department of Cardiology, Herlev and Gentofte University Hospitals, Copenhagen, Denmark.
Morten Salling OlesenThe Danish National Research Foundation Centre for Cardiac Arrhythmia, Copenhagen, Denmark Laboratory of Molecular Cardiology, Department of Cardiology, The Heart Centre, University Hospital of Copenhagen, Rigshospitalet, 9312, Juliane Mariesvej 20, Copenhagen OE 2100, Denmark morten.salling.olesen@gmail.com.
Danish National Research Foundation · DKNovo Nordisk Foundation · DKUniversity of Copenhagen · DKCopenhagen University Hospital · DKCapital Region of Denmark · DKGentofte Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsWe studied whether variants previously associated with congenital long QT syndrome (cLQTS) have an effect on the QTc interval in a Danish population sample. Furthermore, we assessed whether carriers of variants in cLQTS-associated genes are more prone to experience syncope compared with non-carriers and whether carriers have an increased mortality compared with non-carriers. METHODS AND

resultsAll genetic variants previously associated with cLQTS were surveyed using the Human Gene Mutation Database. We screened a Danish population-based sample with available whole-exome sequencing data (n = 870) and genotype array data (n = 6161) for putative cLQTS genetic variants. In total, 33 of 1358 variants previously reported to associate with cLQTS were identified. Of these, 10 variants were found in 8 or more individuals. Electrocardiogram results showed normal mean QTc intervals in carriers compared with non-carriers. Syncope data analysis between variant and non-variant carriers showed that 4 of 227 (1.8%) and 95 of 5861 (1.6%) individuals, respectively, had experienced syncope during follow-up (P = 0.80). There was no significant difference in overall mortality rates between carriers [7/217 (3.2%)] and non-carriers [301/6453 (4.7%)] (P = 0.24).

conclusionWe present QTc data and register data, indicating that 26 cLQTS-associated variants neither had any effect on the QTc intervals nor on syncope propensity or overall mortality. Based on the frequency of individual gene variants, we suggest that the 10 variants frequently identified, assumed to relate to cLQTS, are less likely to associate with a dominant monogenic form of the disease.

Indexed as

DenmarkElectrocardiographyFemaleGenetic Predisposition to DiseaseGenetic VariationGenome-Wide Association StudyHeart RateHeterozygoteHumansLong QT SyndromeMaleMembrane Transport ProteinsMiddle AgedMutationRisk FactorsSyncopeMembrane Transport ProteinsExomeFalse-positive variantsHuman Gene Mutation DatabaseLong QT syndromeLQTS

Identifiers

PMID26159999
OpenAlexW2168732365

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.